SalusInvest earns 3.76 times its original investment from the sale of Crystallon


Salusinvest earned 3.76 times its orginal investments from the sale of Crysallon to Judges Scientific plc.

The  after tax earning multiple was 3.25 times the orginal investments.

The total consideration received from the sale included the initail payment for the Company, the Excess Cash in the business at the the time of sale and approx £600,000 deferred consideration once it was verified that Crystallon had achieved additional growth during the year ending November 30 2017.

(Back to news home)